Status:
RECRUITING
B-Complex: A Nutraceutical SANS Countermeasure
Lead Sponsor:
National Aeronautics and Space Administration (NASA)
Collaborating Sponsors:
Mayo Clinic
Texas A&M University
Conditions:
Optic Disc Edema
Endothelial Dysfunction
Eligibility:
All Genders
20-100 years
Phase:
PHASE1
Brief Summary
In this project, the investigators propose to test effectiveness of a daily nutraceutical supplement containing bioactive B vitamins to mitigate optic disc edema in astronauts. The proposed countermea...
Detailed Description
Fasting (8-h) blood samples (7.5 mL SST and 5 mL EDTA tubes, 12.5 mL total per session) will be collected approximately 180 days and 45 days before flight, on approximate flight day 90, and 30 days be...
Eligibility Criteria
Inclusion
- • Must be astronauts selected for 6-12 month missions on the International Space Station
Exclusion
- • Subjects taking B-vitamin supplements
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2032
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT05366933
Start Date
August 1 2022
End Date
September 30 2032
Last Update
May 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johnson Space Center
Houston, Texas, United States, 77058